RSSS — Research Solutions Income Statement
0.000.00%
Last trade - 00:00- $93.70m
- $86.00m
- $44.62m
- 70
- 45
- 41
- 51
Annual income statement for Research Solutions, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 31.1 | 31.8 | 32.9 | 37.7 | 44.6 |
| Cost of Revenue | |||||
| Gross Profit | 9.64 | 10.3 | 12 | 14.7 | 19.6 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 31.9 | 32 | 34.6 | 37.5 | 45.4 |
| Operating Profit | -0.852 | -0.283 | -1.63 | 0.239 | -0.77 |
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.772 | -0.282 | -1.62 | 0.577 | -3.67 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.78 | -0.285 | -1.63 | 0.572 | -3.79 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -0.662 | -0.285 | -1.63 | 0.572 | -3.79 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.662 | -0.285 | -1.63 | 0.572 | -3.79 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.031 | -0.011 | -0.062 | 0.02 | -0.131 |